Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA)

  • Roberto F E Pedretti
    Cardiovascular Department, IRCCS MultiMedica, Care and Research Institute, Via Milanese 300, Sesto San Giovanni, Milano 20099, Italy
  • Marie-Christine Iliou
    Department of Cardiac Rehabilitation and Secondary Prevention, Hôpital Corentin Celton, Assistance Pulique Hopitaux de Paris centre-Universite de Paris, France
  • Carsten W Israel
    Department of Cardiology, Bethel Clinic, J.W. Goethe University, Frankfurt, Germany
  • Ana Abreu
    Servico de Cardiologia, Hospital Universitário de Santa Maria/Centro Hospitalar Universitário Lisboa Norte (CHULN), Centro Academico de Medicina de Lisboa (CAML), Centro Cardiovascular da Universidade de Lisboa (CCUL), Faculdade de Medicina, Universidade de Lisboa, Portugal
  • Hielko Miljoen
    Department of Cardiology, University of Antwerp and University Hospital Antwerp, Antwerp, Belgium
  • Ugo Corrà
    Department of Cardiac Rehabilitation, ICS Maugeri Care and Research Institute, Veruno, Novara, Italy
  • Christoph Stellbrink
    Department of Cardiology and Intensive Care Medicine, Klinikum Bielefeld GmbH, Bielefeld, Germany
  • Andreas B Gevaert
    Department of Cardiology, University of Antwerp and University Hospital Antwerp, Antwerp, Belgium
  • Dominic A Theuns
    Department of Cardiology, Erasmus MC, Rotterdam, The Netherlands
  • Massimo F Piepoli
    Heart Failure Unit, G. da Saliceto Hospital, AUSL Piacenza and University of Parma, Parma, Italy
  • Rona Reibis
    Department of Rehabilitation Medicine, Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany
  • Jean Paul Schmid
    Department of Cardiology, Clinic Barmelweid, Erlinsbach, Switzerland
  • Matthias Wilhelm
    Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
  • Hein Heidbuchel
    Department of Cardiology, University of Antwerp and University Hospital Antwerp, Antwerp, Belgium
  • Heinz Völler
    Department of Rehabilitation Medicine , Faculty of Health Sciences Brandenburg, University of Potsdam, Potsdam, Germany
  • Marco Ambrosetti
    Cardiovascular Rehabilitation Unit , ASST Crema, Santa Marta Hospital, Rivolta d'Adda, Italy
  • Thomas Deneke
    Heart Center Rhön-Klinikum Campus Bad Neustadt, Bad Neustadt, Germany
  • Veronique Cornelissen
    Cardiovascular Exercise Physiology Unit, Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium
  • Frank R. Heinzel
    Department of Cardiology, Charité—Universitaetsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany
  • Constantinos H Davos
    Cardiovascular Research Laboratory, Biomedical Research Foundation, Academy of Athens, Athens, Greece
  • Gulmira Kudaiberdieva
    SRI of Heart Surgery and Organ Transplantation, Center Scientific Research and Development of Education, Bishkek Kyrgyzstan, Adana, Turkey
  • Ines Frederix
    Hasselt University, Faculty of Medicine & Life Sciences, Hasselt, Belgium
  • Jesper Hastrup Svendsen
    Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • Dominique Hansen
    Heart Centre Hasselt, Jessa Hospital, Hasselt, Belgium

抄録

<jats:title>Abstract</jats:title> <jats:p>Cardiac rehabilitation (CR) is a multidisciplinary intervention including patient assessment and medical actions to promote stabilization, management of cardiovascular risk factors, vocational support, psychosocial management, physical activity counselling, and prescription of exercise training. Millions of people with cardiac implantable electronic devices live in Europe and their numbers are progressively increasing, therefore, large subsets of patients admitted in CR facilities have a cardiac implantable electronic device. Patients who are cardiac implantable electronic devices recipients are considered eligible for a CR programme. This is not only related to the underlying heart disease but also to specific issues, such as psychological adaptation to living with an implanted device and, in implantable cardioverter-defibrillator patients, the risk of arrhythmia, syncope, and sudden cardiac death. Therefore, these patients should receive special attention, as their needs may differ from other patients participating in CR. As evidence from studies of CR in patients with cardiac implantable electronic devices is sparse, detailed clinical practice guidelines are lacking. Here, we aim to provide practical recommendations for CR in cardiac implantable electronic devices recipients in order to increase CR implementation, efficacy, and safety in this subset of patients.</jats:p>

収録刊行物

  • EP Europace

    EP Europace 23 (9), 1336-1337o, 2021-02-26

    Oxford University Press (OUP)

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ